Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Metal ions, including essential elements like iron and copper as well as toxic heavy metals like lead and arsenic, serve as critical biochemical entities that become pharmacological targets in cases of toxicity or overload [1, 2]. In normal physiology, essential metal ions act as indispensable cofactors for thousands of enzymes and provide necessary structural integrity to various proteins; however, their accumulation leads to the generation of reactive oxygen species and subsequent oxidative damage to organs [2, 5]. Metal ion chelators are drugs designed to target these ions by forming stable, non-reactive coordination complexes [1, 3]. These complexes sequester the metal, preventing it from binding to cellular ligands and facilitating its excretion through renal or biliary pathways [1, 2]. This therapeutic strategy is fundamental in treating genetic disorders of metal metabolism, such as Wilson's disease and hereditary hemochromatosis, as well as managing acute and chronic heavy metal poisoning [1, 4].
Chelating agents function by providing multiple ligand atoms (usually oxygen, nitrogen, or sulfur) that form coordinate covalent bonds with a central metal ion, creating a stable, cyclic coordination complex known as a chelate [1, 2]. This sequestration prevents the metal ion from participating in Fenton-type redox reactions that generate toxic hydroxyl radicals and stops the metal from inhibiting essential cellular enzymes [2, 4]. The resulting metal-chelate complex is typically highly water-soluble, which promotes its safe elimination from the body via the urine or feces [1, 3].
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Metal ion.